Loading…
Royalty Pharma plc is projected to rise to $72.77 by 2027, a +28% move from its current price of $56.84. RPRX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $56.02 | $56.83 | $57.65 | -0.01% |
| Jul 13 | $55.69 | $56.82 | $57.98 | -0.02% |
| Jul 14 | $55.43 | $56.82 | $58.24 | -0.03% |
| Jul 15 | $55.21 | $56.81 | $58.46 | -0.04% |
| Jul 16 | $55.02 | $56.81 | $58.65 | -0.05% |
| Jul 17 | $54.85 | $56.80 | $58.82 | -0.06% |
| Jul 18 | $54.69 | $56.80 | $58.98 | -0.07% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $54.69 | $56.80 | $58.98 | -0.07% |
| Week 2 | $53.80 | $56.76 | $59.87 | -0.14% |
| Week 3 | $53.12 | $56.72 | $60.56 | -0.21% |
| Week 4 | $52.55 | $56.68 | $61.13 | -0.28% |
| Week 5 | $52.05 | $56.64 | $61.63 | -0.34% |
| Week 6 | $51.60 | $56.60 | $62.09 | -0.41% |
| Week 7 | $51.18 | $56.56 | $62.51 | -0.48% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases.
The company was founded in 1996 and is based in New York, New York.
Royalty Pharma plc is currently trading at $57.09 per share, with a market capitalization of $32.87B and a market rank of 409. The near-term price outlook is centered around the current level, with the 2026 forecast average price at $57.09. Forecasts show a rising longer-term trajectory, with 2027 avg $74.63, 2030 avg $139.64, and 2050 avg $909.46, accompanied by bullish sentiment across most years.
A major floor 20.2% below — a decisive break under it would weaken the trend.
The nearest floor, 6.8% below — buyers have tended to step in here.
Price is pressing into resistance (2.7% away) — a breakout level to watch.
A major ceiling 7.9% above — clearing it would confirm fresh momentum.
Key RPRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RPRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $57.50 | Sell | $57.23 | Sell |
| MA 10 | $57.04 | Sell | $56.85 | Sell |
| MA 20 | $55.68 | Buy | $56.06 | Buy |
| MA 50 | $54.03 | Buy | $53.99 | Buy |
| MA 100 | $50.55 | Buy | $50.89 | Buy |
| MA 200 | $44.76 | Buy | $46.38 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.90 | Neutral |
| Stoch RSI (14) | 29.35 | Neutral |
| CCI (20) | 36.70 | Neutral |
| Williams %R (14) | -40.42 | Info |
| MACD (12,26,9) | 0.08 | Buy |
| ROC (12) | 1.95 | Buy |
| Bollinger %B (20,2) | 0.62 | Neutral |
| Stochastic %K (14) | 59.58 | Neutral |
| TRIX (15) | 0.24 | Buy |
| Awesome (5,34) | 2.21 | Buy |
| Ultimate (7,14,28) | 55.37 | Neutral |
| Momentum (10) | 1.74 | Buy |
| Aroon Osc (25) | 48.00 | Buy |
| Hull MA (9) | 57.99 | Sell |
| ADX (14) | 20.07 | Buy |
| ATR (14) | 0.85 | Info |
The near-term technical picture is bullish by sentiment. The RSI(14) is 60, signaling moderate momentum. The 50-day simple moving average is $52.82 and the 200-day simple moving average is $43.91, indicating the price is above both moving averages and has room to advance.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $38.86 | $56.84 | $71.79 | 0% | Neutral | |
| $59.59 | $72.77 | $92.90 | +28% | Bullish | |
| $68.41 | $85.10 | $111.57 | +50% | Bullish | |
| $82.75 | $104.53 | $139.97 | +84% | Bullish | |
| $103.38 | $132.34 | $180.41 | +133% | Bullish | |
| $110.47 | $143.15 | $198.22 | +152% | Bullish | |
| $117.97 | $154.60 | $217.12 | +172% | Bullish | |
| $131.77 | $174.50 | $248.25 | +207% | Bullish | |
| $140.25 | $187.57 | $270.03 | +230% | Bullish | |
| $166.84 | $225.25 | $327.88 | +296% | Bullish | |
| $244.17 | $343.83 | $524.48 | +505% | Bullish | |
| $535.43 | $808.63 | $1,322.19 | +13.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $38.86 | $56.84 | $66.73 | +0.00% |
| August 2026 | $47.29 | $55.36 | $66.22 | -2.59% |
| September 2026 | $47.88 | $56.33 | $67.90 | +1.74% |
| October 2026 | $49.04 | $57.93 | $70.29 | +2.84% |
| November 2026 | $48.87 | $57.93 | $70.67 | -0.00% |
| December 2026 | $49.23 | $58.54 | $71.79 | +1.06% |
Click any year to see its month-by-month RPRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, RPRX could reach as high as $71.79, with a base case around $56.84 and support toward $38.86 — roughly 0% from $56.84. A consolidation phase looks the most probable path here.
Expect RPRX to range from $59.59 to $92.90 through 2027. The $72.77 average target implies a +28% move from current prices. That is up +28% on the projected 2026 average. Momentum favours further upside here.
The RPRX price prediction for 2028 points to an average of $85.10 (low $68.41, high $111.57) — a potential gain of +50% on today's $56.84. Buyers look set to stay in control over this stretch.
In 2029, RPRX is projected to trade between $82.75 and $139.97, averaging $104.53 — a potential gain of +84% from today's $56.84. That is up +23% on the projected 2028 average. Momentum favours further upside here.
Royalty Pharma plc's 2030 outlook centres on $132.34, within a $103.38 to $180.41 range. That is up +27% on the projected 2029 average. That marks a +133% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, RPRX could reach as high as $198.22, with a base case around $143.15 and support toward $110.47 — roughly +152% from $56.84. Momentum favours further upside here.
Expect RPRX to range from $117.97 to $217.12 through 2032. The $154.60 average target implies a +172% move from current prices. That is up +8% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The RPRX price prediction for 2033 points to an average of $174.50 (low $131.77, high $248.25) — a potential gain of +207% on today's $56.84. Momentum favours further upside here.
In 2034, RPRX is projected to trade between $140.25 and $270.03, averaging $187.57 — a potential gain of +230% from today's $56.84. That is up +7% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Royalty Pharma plc's 2035 outlook centres on $225.25, within a $166.84 to $327.88 range. That is up +20% on the projected 2034 average. That marks a +296% change versus current levels. Momentum favours further upside here.
By 2040, RPRX could reach as high as $524.48, with a base case around $343.83 and support toward $244.17 — roughly +505% from $56.84. Buyers look set to stay in control over this stretch.
Expect RPRX to range from $535.43 to $1,322.19 through 2050. The $808.63 average target implies a +13.2x move from current prices. That is up +135% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in RPRX today (≈ 17.594792 RPRX) could be worth
$14,227.65
+$13,227.65 (+1323%) by 2050 · US Dollar
Based on the average projected RPRX price of $808.63 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RPRXwould be worth at today's price.
$1,000 invested in RPRX on Jul 10, 2025 (≈ 27.685494 RPRX) would be worth
$1,573.51
+$573.51 (+57.4%) today · 1.57× · US Dollar
Based on a RPRX entry price of $36.12 vs. today's $56.84.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $57.77 | $983.82 | -1.6% |
| 1 month ago | $54.52 | $1,042.46 | +4.2% |
| 3 months ago | $47.9 | $1,186.53 | +18.7% |
| 6 months ago | $40.26 | $1,411.7 | +41.2% |
| 1 year ago | $36.12 | $1,573.51 | +57.4% |
| All time (5.0y) ago | $41.71 | $1,362.62 | +36.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RPRX forecast.
Our base-case forecast reaches $110.00 around 2030.
Implied market cap at $110.00: $48.76B
Across the multi-year forecast, the outlook is strongly bullish with rising price expectations and substantial ROI increases. The 2030 avg is $139.64 with ROI 144.6, the 2040 avg is $372.33 with ROI 552.2, and the 2050 avg is $909.46 with ROI 1493, underscoring a persistent upward trajectory. Key intermediate milestones include 2027 avg $74.63, 2028 avg $87.84, and 2029 avg $110.28, with continued bullish sentiment through 2035 and beyond.
These projections reflect a broad-based portfolio and ongoing collaboration efforts, but they remain estimates and are not guarantees.
Tap a question to reveal the answer.
The 2030 forecasted avg price is $139.64 with a min of $109.03 and a max of $190.44, and ROI of 144.6, with bullish sentiment.
Forecasts show bullish sentiment from 2027 onward, with rising averages (e.g., 2027 avg $74.63 and 2030 avg $139.64) and increasing ROI (e.g., 144.6 in 2030 and 1493 in 2050). These are estimates and not guarantees.
Yes. The forecasted maximum values reach above $200 in multiple years: 2031 max $207.88, 2034 max $289.22, 2035 max $357.36, 2040 max $568.09, and 2050 max $1,487.32.
Current price is $57.09 and market capitalization is $32.87B, with a market rank of 409.
The near-term outlook is bullish with RSI(14) at 60, SMA50 at $52.82, SMA200 at $43.91, support at $52.07, resistance at $57.09, and a 30-day range of $52.36 to $62.25; annualized volatility is 30.
Royalty Pharma plc Community Discussion
0Share your Royalty Pharma plc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.